Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
about
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesMicroRNAs and Potential Targets in Osteosarcoma: ReviewMesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapyP16INK4a overexpression and survival in osteosarcoma patients: a meta analysisCD271+ osteosarcoma cells display stem-like propertiesNew small molecules targeting apoptosis and cell viability in osteosarcomaA RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma(#).An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model.Pediatric Osteosarcoma: An Updated ReviewTissue factor associates with survival and regulates tumour progression in osteosarcoma.Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem CellsE2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα.Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcomaStem cells and bone diseases: new tools, new perspectiveHuman umbilical cord mesenchymal stem cells and derived hepatocyte-like cells exhibit similar therapeutic effects on an acute liver failure mouse modelIdentification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data.Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.Targeting the osteosarcoma cancer stem cellThe Role of RUNX2 in Osteosarcoma Oncogenesis.The genetics of osteosarcoma.Mesenchymal stem cell transformation and sarcoma genesis.Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells.Asymmetric aneuploidy in mesenchymal stromal cells detected by in situ karyotyping and fluorescence in situ hybridization: suggestions for reference values for stem cells.In silico functional analyses and discovery of survival-associated microRNA signatures in pediatric osteosarcoma.Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential.Alteration of histone acetylation pattern during long-term serum-free culture conditions of human fetal placental mesenchymal stem cells.p53 loss increases the osteogenic differentiation of bone marrow stromal cellsMesenchymal stem cells: from experiment to clinic.Hypoxia, stem cells and bone tumorTranscriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation.Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture.Putative multifunctional signature of lung metastases in dedifferentiated chondrosarcoma.Osteosarcoma models: from cell lines to zebrafishComments on Bu et al. "P16(INK₄a) overexpression and survival in osteosarcoma patients: a meta analysis"Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investmentGenetically engineered mouse models and human osteosarcoma.The molecular landscape of extraskeletal osteosarcoma: A clinicopathological and molecular biomarker study.
P2860
Q26745742-1B39D494-7EC9-4FAA-8EFB-DC827D8E828BQ26784033-85DFCCB7-AFDE-4680-8336-BA9199A9314EQ26825272-2951230D-0226-4886-BFEF-C23E436F9D5BQ27009461-5792BC83-4CBD-498C-B488-A1BDCC7E4EDEQ28539288-78CAF432-0F6A-474A-9607-A9EA4B760058Q28547760-A1228FF3-8997-4D41-B780-BD2BAB58003AQ28550430-8FB847B2-A97A-4207-8551-B7C6C185E246Q33274565-E30E87A1-C8A9-4247-8340-76BA581484F2Q33275167-B7C6897E-2881-457B-9A37-5BA87B25DAFFQ33579181-68FC47CE-C6DD-4455-AE79-7442345AE39BQ33583291-C84F3AFA-4F39-4B2B-B717-B35BAE632E20Q33672303-C9DC42BC-E4A7-4D75-BB77-549BD5815E46Q33722454-1652D74E-EAB4-42A3-8B1F-2DD7062077CDQ33728384-B1A00D36-4DE3-4A62-87BB-B2252EECC7C9Q33779486-757B99B3-6DD5-4EAC-8158-BF160F4EE296Q33925049-EC6CA063-4DCF-4112-BB3A-DCF4C24E3306Q34015597-C9E3B659-A1D3-4218-9F19-546C95CDF5F2Q34210358-73F8D853-C8B4-4D1A-B8BD-75794FEC93E2Q34220071-9D2EF215-EA79-4BDF-8D73-88D4DA873364Q34335524-45671C4F-C627-48E0-B5B8-175100D54758Q34423871-361BB8DA-69A2-4348-AC26-D7C8D624B5B0Q34639086-24FB154A-F24B-49AF-8712-E9CA50916D92Q34654560-B7ECBE47-5421-44AD-AB5E-2551A0F1F02DQ34700290-7049B50D-731D-4C54-9E18-B885CF7AA688Q34751375-A2346C76-F06E-46B7-8236-ECEC5B0E0836Q34781386-CE6C85C7-F5AC-4522-B708-32276B20A49CQ35021459-76B942BC-6F66-4AC3-BDDB-A894E2437615Q35073567-8BB91EF4-BC6B-45E9-B0C5-A2301E8AAD5BQ35224427-8006C88C-CC3A-4877-8AC5-CE9956C45888Q35240668-DDC73B64-8BA3-4EA1-AAA1-BB57E5743D35Q35549238-9869822F-6AA3-4862-B311-4FD5ACBF6673Q35610677-21EAB008-724E-442C-84B2-363939DFC608Q35619493-9102D105-87CD-429E-96B7-6B58A306C5BFQ35770479-8C09DA16-0D10-4E5D-90EB-C36C051F3A9AQ35789112-98040536-5F27-40F4-91AB-90508BFF8425Q35897787-98B70558-C53E-4AB4-BB3C-31534D9F8F19Q35919598-7D5EBF07-267B-43F9-81DF-12A6387CBA46Q35958048-87EEFDBE-89F9-4113-9425-2237C3BC9764Q36468644-ED2A85CC-3671-455C-B00B-EF52EBF72F7DQ36873828-D185D753-8287-4573-B48C-860413DE5E3A
P2860
Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Osteosarcoma originates from m ...... ion and genomic loss of Cdkn2.
@ast
Osteosarcoma originates from m ...... ion and genomic loss of Cdkn2.
@en
Osteosarcoma originates from m ...... ion and genomic loss of Cdkn2.
@nl
type
label
Osteosarcoma originates from m ...... ion and genomic loss of Cdkn2.
@ast
Osteosarcoma originates from m ...... ion and genomic loss of Cdkn2.
@en
Osteosarcoma originates from m ...... ion and genomic loss of Cdkn2.
@nl
prefLabel
Osteosarcoma originates from m ...... ion and genomic loss of Cdkn2.
@ast
Osteosarcoma originates from m ...... ion and genomic loss of Cdkn2.
@en
Osteosarcoma originates from m ...... ion and genomic loss of Cdkn2.
@nl
P2093
P50
P356
P1476
Osteosarcoma originates from m ...... tion and genomic loss of Cdkn2
@en
P2093
Alexander B Mohseny
Anne-Marie Cleton-Jansen
Inge Briaire-de Bruijn
Melissa van Pel
Salvatore Romeo
P304
P356
10.1002/PATH.2603
P577
2009-11-01T00:00:00Z